Zygmont Chester Stanley III
Transaction: 04/30/2026
SELL
Change
-13,285
Price
$1.10
Filing
05/01/2026
Type
SELL
Revelation Biosciences, Inc.
REVB • Biotechnology
Strong market move
REVB+14.15%
vs. previous close $3.29
$3.75
▲ +0.46 (+14.15%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.36M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.08Healthy liquidity · 5.41Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.75
Change14.15%
Shares Out3.83M
Market Cap$14.36M
Enterprise Value$3.62M
52W Range0.88 - 11.72
Beta-0.17
P/E-1.34
P/B1.43
P/FCF-1.13
EV/EBITDA-0.33
EV/FCF-0.28
Price$3.75
Change14.15%
Shares Out3.83M
Market Cap$14.36M
Enterprise Value$3.62M
52W Range0.88 - 11.72
Beta-0.17
P/E-1.34
P/B1.43
P/FCF-1.13
EV/EBITDA-0.33
EV/FCF-0.28
Earnings Yield-74.86%
FCF Yield-88.62%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.08
Current Ratio5.41
Quick Ratio5.41
Volume25.15K
Avg Volume52.25K
EPS Surprise-1.56
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.08Healthy liquidity · 5.41Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-21
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Rolke James
Transaction: 04/30/2026
SELL
Change
-10,115
Price
$1.13
Filing
05/01/2026
Type
SELL
Zygmont Chester Stanley III
Transaction: 02/04/2026
SELL
Change
-13,100
Price
$1.65
Filing
02/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Zygmont Chester Stanley III | SELL | -13,285 | $1.10 | 04/30/2026 | 05/01/2026 |
| Rolke James | SELL | -10,115 | $1.13 | 04/30/2026 | 05/01/2026 |
| Zygmont Chester Stanley III | SELL | -13,100 | $1.65 | 02/04/2026 | 02/05/2026 |
| Rolke James | SELL | -8,521 | $1.86 | 02/03/2026 | 02/05/2026 |
| CARVER JENNIFER | SELL | -1,661 | $1.87 | 02/03/2026 | 02/05/2026 |
| Chawla Lakhmir S | SELL | -2,261 | $1.85 | 02/03/2026 | 02/05/2026 |
| ROPER JESS | SELL | -1,591 | $1.85 | 02/03/2026 | 02/05/2026 |
| Chawla Lakhmir S | BUY | +41,981 | $0.90 | 01/08/2026 | 01/12/2026 |
| ROPER JESS | BUY | +41,981 | $0.90 | 01/08/2026 | 01/12/2026 |
| CARVER JENNIFER | BUY | +41,981 | $0.90 | 01/08/2026 | 01/12/2026 |
| Zygmont Chester Stanley III | BUY | +78,145 | $0.90 | 01/08/2026 | 01/12/2026 |
| Rolke James | BUY | +532,829 | $0.90 | 01/08/2026 | 01/12/2026 |
| ROPER JESS | BUY | +15,625 | $1.28 | 10/29/2025 | 10/31/2025 |
| Zygmont Chester Stanley III | BUY | +390,614 | $1.28 | 10/29/2025 | 10/31/2025 |
| CARVER JENNIFER | BUY | +15,625 | $1.28 | 10/29/2025 | 10/31/2025 |
| Rolke James | BUY | +390,614 | $1.28 | 10/29/2025 | 10/31/2025 |
| Chawla Lakhmir S | BUY | +15,625 | $1.28 | 10/29/2025 | 10/31/2025 |
| TIDMARSH GEORGE F | BUY | +181 | $3.87 | 02/11/2025 | 02/13/2025 |
| Zygmont Chester Stanley III | BUY | +15,048 | $3.87 | 02/11/2025 | 02/13/2025 |
| Rolke James | BUY | +30,095 | $3.87 | 02/11/2025 | 02/13/2025 |